Europe Continuous Glucose Monitoring Systems Market with business opportunities and threats, challenges to industry growth during forecast period
Europe Continuous Glucose Monitoring Systems Market was valued $58 million in 2015, and is expected to reach $792 million by 2022, supported by a CAGR of 44.9% during the forecast period 2016 - 2022. The sensors segment is anticipated to generate the highest revenue in this market during the forecast period.
Renowned companies, such as Senseonics and Rubin Medical, have adopted collaboration as their key strategy to commercialize their CGMS products in Denmark and Sweden. An increasing number of diabetic patients, well-structured diabetes management regime, and proactive initiatives taken by the government have encouraged several CGMS companies to invest in Europe.
Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/862?utm_source=sy
Key players profiled in this report include
• Abbott Laboratories
• DexCom Inc.
• Echo Therapeutics Inc.
• Insulet Corporation
• Johnson & Johnson
• Medtronic plc
• Senseonics Holding Inc.
• F. Hoffmann-La Roche Ltd.
Other players (not profiled in this report) operating in this market include AgaMatrix, Inc., GlySure, OrSense, and Ypsomed.
Sensors market contributed for the highest share of revenue in the CGMS market. In addition, the market is expected to witness the highest growth during the analysis period, as CGM sensors are changed frequently as compared to transmitters & receivers. As the percentage of adult population is high, this segment is estimated to generate the largest market revenue. However, owing to the growth in demand for CGM devices for children, the children population segment may grow at a higher CAGR.
Based on end-user market analysis, diagnostics/clinics contributed the highest share to the market revenue. The network of health insurers with the physicians operating at the diagnostics/clinics level is expected to drive the CGMS market in European diagnostics/clinics.
Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/862?utm_source=sy
However, high growth of the home healthcare segment is expected, as this segment is economic as compared to treatment from healthcare institutions. In addition, home healthcare would be the suitable solution for geriatric and children population who cannot visit the clinics for diabetes treatment.
Key findings of Europe Continuous Glucose Monitoring Systems Market:
• UK is projected to grow at the highest CAGR during the forecast period.
• Germany generated about one-fifth of the total market revenue in 2015, and is projected to be the maximum revenue-generating country by 2022.
• Sensors segment accounted for more than three-fifths of the market revenue in 2015 and is projected to exhibit prominent growth during the forecast period.
• Home healthcare and diagnostic/clinics contributed over half of the market share in 2015.
Region wise, Germany leads the market, in terms of revenue, owing to favorable guidelines about pricing and fixed reimbursement budget allocation for CGM devices. In addition, the market is estimated to exhibit significant growth in Norway, Sweden, and Denmark owing to the availability of advanced diabetes care facilities, and robust clinical guidelines and standards for diabetes management.
Access Full Summery @ https://www.alliedmarketresearch.com/Europe-Continuous-Glucose-Monitoring-Systems-market?utm_source=sy
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Europe Continuous Glucose Monitoring Systems Market with business opportunities and threats, challenges to industry growth during forecast period here
News-ID: 1659033 • Views: 165
More Releases from Allied Market Research
North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently
More Releases for CGM
Global Continuous Glucose Monitoring Devices (CGM) Market
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Continuous Glucose Monitoring Device Market. The report analyzes the Global Continuous Glucose Monitoring Market by Component (Transmitter & receiver, sensor, Integrated Insulin Pump), By Demographics (Pediatric, Adult), By End user (Homecare, Hospital), By Region (North America, Europe, Asia Pacific, Rest of the world)
Canada Insulin Pump & CGM Industry 2018
Canada Insulin Pump & CGM Industry Although Canada insulin pump market is small but it has market potential to reach nearly CAD 1 Billion mark by the end of year 2024. Similarly CGM market is also small but if it gets reimbursement under Canadian government then it has market potential to surpass CAD 80 Million by 2024. The government of Canada has expanded its diabetes management policy along with diabetes technology which will
Global CGM Market, Users, Reimbursement Policy, CGM Components (Glucose Sensor, …
Researchmoz added Most up-to-date research on "Global CGM Market, Users, Reimbursement Policy, CGM Components (Glucose Sensor, Transmitter) Market, Diabetes (Type1 & 2) Population, & Forecast" to its huge collection of research reports. Global CGM market will be an US$ 4 Billion opportunity by 2024. This report provides the market data on, continuous glucose monitoring (CGM) systems market of 11 countries globally. In the report CGM market has been divided into 2
CGM Market, Users, Reimbursement Policy, CGM Components (Glucose Sensor, Transmi …
Global CGM market will be an US$ 4 Billion opportunity by 2024. This report provides the market data on, continuous glucose monitoring (CGM) systems market of 11 countries globally. In the report CGM market has been divided into 2 components: glucose sensors and CGM transmitters. Transmitters & receivers along with sensors are known as standalone CGM systems, which are preinstalled by manufacturer. Sensors are disposable items, which is replaced after
Global Continuous Glucose Monitoring (CGM) Market,
The Global Continuous Glucose Monitoring Market (CGM) was valued at US$ 444.0 million in 2015 and is projected to reach US$ 1,025.2 million by 2024, according to a new report by published by Coherent Market Insights. CGM devices allow monitoring of glucose level during bedtime, noon, pre/post lunch, or before/after exercise, which is a major factor propelling growth of the continuous glucose monitoring market. The global CGM market is undergoing a
Shipping Containers Market 2017- CIMC, SINGAMAS, Sea Box, CMA CGM
MarketInsights.Biz, recently published a detailed market research study focused on the "Shipping Containers Market" across the global, regional and country level. The report provides 360° analysis of "Shipping Containers Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Shipping Containers industry, and estimates the future trend of Shipping Containers market on the